Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125056) titled 'Investigating the Application of Microbiota Capsules in Patients with Clostridioides difficile Infection After Chemotherapy' on May 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Xiamen University
Condition:
Clostridioides difficile infection
Intervention:
Normal dosage group:Take healthy human intestinal flora capsules orally, 20 capsules a day, for 3 consecutive days, a total of 60 capsules
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-22
Target Sample Size: Normal dosage group:10;High dose group:10; ...